N-Acetylcysteine (NAC): Uses, Benefits, and Side Effects

N-acetylcysteine, commonly called NAC, is a modified form of the amino acid cysteine that has been used medically since the 1960s and has accumulated one of the most eclectic resumes of any pharmaceutical compound. Its best-known role is as the antidote for acetaminophen poisoning, where it can prevent fatal liver damage if given promptly. But researchers have tested it against an unusually wide range of conditions, from compulsive hair-pulling to infertility to kidney damage from medical imaging dye. The reason it keeps showing up in such different contexts comes down to a single biochemical trick that turns out to matter almost everywhere in the body.

How NAC Works in the Body

NAC’s primary value is as a raw material for glutathione, the body’s most abundant internally produced antioxidant. Glutathione protects cells from oxidative damage, helps detoxify harmful substances, and participates in immune signaling. When the body is under stress from poisoning, chronic disease, or intense inflammation, glutathione reserves can become depleted. NAC restores them by supplying cysteine, the building block that limits how fast the body can make new glutathione.¹ Under conditions of severe depletion, NAC can also act as a direct antioxidant on its own, scavenging certain reactive molecules before they damage cells.²

Beyond antioxidant duty, NAC influences mucus consistency (it breaks the disulfide bonds that make mucus thick and sticky), modulates inflammation pathways, and affects glutamate signaling in the brain. That last property is what drew psychiatry researchers to it. This combination of mechanisms explains why NAC keeps appearing in studies of seemingly unrelated diseases: oxidative stress and glutathione depletion are features of a remarkably broad list of conditions.³

One thing worth knowing early: oral NAC has low bioavailability. Studies estimate that only about 5 to 12 percent of an oral dose reaches the bloodstream intact, with the rest broken down during first-pass metabolism in the gut and liver.⁴⁵ That does not mean oral NAC is useless — plenty of it still gets converted to cysteine and fed into glutathione synthesis — but it does explain why emergency-room protocols for poisoning use intravenous delivery instead.

The Acetaminophen Antidote

NAC’s most established medical use is treating acetaminophen (paracetamol) overdose, and this is the context where no serious debate remains about its effectiveness. When someone takes a dangerous amount of acetaminophen, the liver’s normal detoxification pathways become overwhelmed, and a toxic byproduct called NAPQI accumulates. Glutathione normally neutralizes NAPQI, but once glutathione stores are exhausted, NAPQI destroys liver cells. NAC floods the body with the raw material to regenerate glutathione and directly helps detoxify NAPQI.

Timing is critical. A landmark study found that when NAC was started within 10 hours of an acetaminophen overdose, liver toxicity developed in only about 6 percent of at-risk patients. When treatment was delayed to 10 to 24 hours after ingestion, that rate rose to about 26 percent.⁶ Even patients treated 16 to 24 hours after an overdose showed better outcomes than untreated historical controls, so late treatment is still recommended, but early treatment is far more protective. The general clinical consensus is that NAC should be started within eight hours of an acetaminophen overdose for the best chance of preventing liver failure, while remaining indicated for at least 24 hours after ingestion.⁷⁸

Respiratory Uses and COPD

NAC has long been marketed in parts of Europe as a mucolytic — a drug that thins thick mucus in the airways. It breaks disulfide bonds in mucus glycoproteins, making secretions less viscous and theoretically easier to clear. For decades this was the main reason you could buy it over the counter in many countries, and it remains a common respiratory prescription in some healthcare systems.⁹

The more interesting question is whether long-term NAC use can reduce flare-ups in people with chronic obstructive pulmonary disease (COPD). A meta-analysis of randomized trials found that long-term NAC therapy (six months or more) did reduce the risk of COPD exacerbations, though it did not improve lung function measures like forced expiratory volume.¹⁰ A large 2024 randomized trial in patients with mild-to-moderate COPD added nuance: high-dose NAC did not significantly reduce total exacerbations overall, but moderate or severe exacerbations were about 24 percent lower in the NAC group compared to placebo.¹¹ So NAC may help prevent the worst flare-ups in COPD without changing day-to-day lung function. That is a meaningful but limited benefit, and it helps explain why guidelines in different countries disagree about recommending it.

Mental Health and Compulsive Behaviors

NAC’s ability to modulate glutamate, the brain’s main excitatory signaling molecule, drew psychiatric researchers to test it for conditions where glutamate balance seems disrupted. The most convincing results so far have come from trichotillomania, the compulsive urge to pull out one’s own hair. A double-blind, placebo-controlled trial in adults found that 56 percent of participants taking NAC were rated as “much or very much improved” after 12 weeks, compared to 16 percent on placebo.¹² Participants showed measurable improvements in both the severity of their hair-pulling urges and their ability to resist them.¹³

There is a notable catch: the same researchers ran a follow-up trial in children and adolescents with trichotillomania and found no significant benefit over placebo.¹⁴ Whether NAC works differently in developing brains or whether the pediatric study was simply too small to detect an effect remains unclear. For now, the adult evidence is encouraging, and some clinicians use NAC off-label for body-focused repetitive behaviors, but the pediatric picture is uncertain.

For major psychiatric disorders, the results are more mixed. A meta-analysis of randomized trials found that NAC as an add-on treatment significantly improved overall symptom scores in schizophrenia but showed little meaningful benefit for depressive episodes or the manic symptoms of bipolar disorder.¹⁵ A later, larger trial specifically targeting negative symptoms of treatment-resistant schizophrenia found no improvement with NAC over a full year.¹⁶ The early optimism about NAC as a broad psychiatric supplement has not held up well under rigorous testing, though specific applications like trichotillomania still look promising.

Substance Use and Cravings

A separate line of research has explored whether NAC can help with addiction by restoring glutamate balance in reward circuits that become dysregulated with chronic substance use. A meta-analysis of randomized trials found that NAC produced a moderate reduction in craving symptoms across several substances and also improved withdrawal and depressive symptoms compared to controls.¹⁷ Individual trials have shown some promise for cocaine, nicotine, and cannabis, though results across studies have been inconsistent, and no large definitive trial has yet established NAC as a standard treatment for any substance use disorder.¹⁸ It falls into the category of an interesting adjunct that needs more and bigger studies before anyone can confidently recommend it as a clinical tool for addiction.

Protecting the Kidneys From Contrast Dye

When hospitals inject iodine-based contrast dye for imaging procedures like coronary angiography or CT scans, some patients develop contrast-induced nephropathy, a sudden decline in kidney function. NAC has been studied as a preventive measure because oxidative stress plays a role in this type of kidney injury. A meta-analysis covering more than 11,000 participants found that patients who received NAC had a lower rate of contrast-induced kidney injury compared to controls — roughly 13 percent versus 16 percent. The protective effect was clearest for patients undergoing coronary angiography and CT scans, while the benefit for peripheral angiography was not apparent.¹⁹

In a trial focused on patients undergoing emergency heart procedures, the results were starker. High-dose intravenous NAC reduced the rate of kidney injury from about 33 percent in the control group to 8 percent, and in-hospital mortality dropped from 11 percent to 3 percent in the high-dose group.²⁰ Despite these findings, the question remains somewhat unsettled. Some later trials have been less impressive, and guidelines in different countries take different positions on whether to routinely give NAC before contrast procedures. Intravenous hydration remains the primary prevention strategy, with NAC used as an additional measure in some protocols.²¹

Fertility in Men and Women

Oxidative stress is increasingly recognized as a factor in both male and female infertility, which has made NAC a natural candidate for study in reproductive medicine. In men with poor sperm quality, supplementation with NAC has been shown to improve sperm motility, concentration, morphology, and DNA integrity across multiple small trials.²²²³ The improvements are real but modest in absolute terms, and no large trial has yet shown that NAC supplementation translates into higher pregnancy rates for couples dealing with male-factor infertility.

In women with polycystic ovary syndrome (PCOS), the evidence is more developed. A systematic review of randomized trials found that NAC improved the odds of ovulation, pregnancy, and live birth compared to placebo, though it was less effective than metformin, the current standard pharmacological option for PCOS-related fertility issues.²⁴ A more recent study that combined animal and human data found that NAC supplementation improved insulin sensitivity in PCOS and reduced the amount of fertility medication needed during ovulation induction. Cumulative pregnancy rates were significantly higher in the NAC group than in controls.²⁵ For women with PCOS who cannot tolerate metformin or who want to add something alongside it, NAC is gaining traction as a complementary option.

Influenza and Viral Infections

A randomized trial of 262 elderly subjects who took 600 mg of NAC twice daily throughout the winter found something counterintuitive. NAC did not prevent influenza infection — blood tests showed similar rates of seroconversion in both groups. But among those who did get infected, only 25 percent of the NAC group developed symptoms, versus 79 percent in the placebo group.²⁶ Both the severity and the number of days spent bedridden were significantly lower. This remains one of the more remarkable findings in the NAC literature, though it is a single trial from the late 1990s and has never been replicated at scale. Laboratory work has shown that NAC inhibits replication and inflammatory signaling of highly pathogenic influenza strains in cell culture, providing a plausible mechanism.²⁷ During the COVID-19 pandemic, some researchers proposed NAC as a supportive treatment based on similar logic, but the clinical evidence for that specific application remains thin.

Blood Vessels and Heart Health

NAC has shown an ability to improve endothelial function — the capacity of blood vessel walls to relax and dilate appropriately. In one study, NAC boosted the coronary blood flow response to a vasodilator by about 36 percent, and the effect was similar whether or not patients had existing atherosclerosis.²⁸ In patients with end-stage kidney disease, NAC during dialysis reduced homocysteine levels and improved pulse pressure and endothelial function.²⁹ Long-term combined treatment with NAC and L-arginine has also been studied in hypertensive patients with type 2 diabetes, with results suggesting improved endothelial function and lower blood pressure.³⁰

These cardiovascular findings are intriguing but come from relatively small studies. Nobody is prescribing NAC as a heart medication, and there are no large outcomes trials showing it prevents heart attacks or strokes. The endothelial effects do, however, offer a plausible reason why NAC might prove useful as a complementary treatment in metabolic conditions where blood vessel health is compromised.

Eyes, Skin, and Hearing

NAC shows up in research across a surprising range of specialties. In ophthalmology, topical NAC eye drops have been tested for dry eye disease, corneal healing after chemical injury, and even as a possible treatment for conditions like cataracts and macular degeneration.³¹ A controlled trial of a chitosan-NAC eye drop formulation showed that it significantly increased tear film thickness and reduced symptoms in patients with dry eyes.³²

In dermatology, case reports and small trials have reported benefits for conditions including acne, wound healing, photoprotection, and the skin-picking and nail-biting disorders that overlap with the compulsive behavior research described earlier.³³ The evidence base is thin for most of these applications — often just case series or pilot studies — but NAC’s safety profile makes it appealing for exploratory use.

For hearing loss, the picture is less encouraging. A meta-analysis found that NAC did not have a meaningful overall effect on sensorineural hearing loss. The one exception was sudden hearing loss, where NAC treatment was associated with improved outcomes on hearing tests.³⁴ Researchers have been particularly interested in whether NAC can prevent hearing damage from cisplatin, a chemotherapy drug notorious for causing permanent hearing loss. A systematic review found no significant protection from either oral or injected NAC, with only a hint of benefit at very high sound frequencies.³⁵

Safety and Side Effects

NAC has a reputation as one of the safer drugs in medicine, and that reputation is largely deserved — with caveats. In oral supplement form at doses between 600 and 1,800 mg per day, most people tolerate it well, though nausea, diarrhea, and a sulfurous taste or smell are common complaints. The more serious concerns arise with intravenous use, particularly the rapid-infusion protocols used in acetaminophen poisoning. Reactions that resemble anaphylaxis — rash, itching, swelling, bronchospasm, and rarely low blood pressure — have been documented, though these are caused by non-immune mechanisms and are usually dose-rate dependent rather than true allergies.³⁶

People with asthma are nearly three times more likely to develop side effects from intravenous NAC compared to non-asthmatics, so extra caution and monitoring are standard in that population.³⁷ Incorrect dosing, particularly of the intravenous form, has been associated with the most severe adverse events, including rare fatalities. This is almost exclusively a concern in the emergency medicine setting, not with oral supplementation.

One quirk of NAC worth noting for supplement users: in 2020, the U.S. FDA sent warning letters to supplement companies marketing NAC, arguing that it was approved as a drug before it was sold as a supplement, which potentially disqualified it from being marketed as a dietary supplement under U.S. law. The supplement industry pushed back, and as of the time of writing, NAC remains widely available for purchase in the United States, though the regulatory ambiguity has not been fully resolved. In most other countries it is sold as either an over-the-counter medication or a supplement without controversy.

Where NAC Pans Out and Where It Disappoints

What makes NAC fascinating is the gap between its biological plausibility and its clinical track record. Oxidative stress plays a role in almost every chronic disease, so a safe, cheap glutathione precursor sounds like it should help with everything. In practice, the slam-dunk application remains acetaminophen poisoning, where the mechanism is direct and the evidence is overwhelming. The second-best evidence is probably for reducing the more serious COPD flare-ups and for preventing contrast-induced kidney injury in cardiac procedures, though both remain somewhat contested. Trichotillomania in adults, PCOS-related fertility support, and possibly winter respiratory infections round out the areas where real trials have shown meaningful benefits.

For the many other conditions where NAC has been tested — major depression, bipolar disorder, treatment-resistant schizophrenia, cisplatin-induced hearing loss, general sensorineural hearing loss — the evidence has been disappointing or at best inconclusive. The pattern suggests that simply topping up glutathione is not a universal fix. Conditions where a specific, acute depletion of glutathione drives the pathology (like acetaminophen poisoning or contrast dye injury) respond well. Conditions where oxidative stress is one contributor among many (like chronic psychiatric illness) tend to yield small or inconsistent effects. That distinction is useful for anyone evaluating whether NAC is worth trying for a particular health concern: ask whether the problem involves a concrete, measurable depletion that NAC can refill, or a complex chronic process where oxidative stress is just one piece of a much larger puzzle.